FIA
CDLX icon

FNY Investment Advisers’s Cardlytics CDLX Stock Holding History

FNY Investment Advisers’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,367
Closed -$33K – 998
2025
Q3 		$33K Buy
+1,367
New +$22.8K 0.01% 589
2024
Q3 		– Sell
-750
Closed -$61K – 691
2024
Q2 		$61K Sell
750
-2,728
-78% -$295K 0.04% 229
2024
Q1 		$503 Buy
+3,478
New +$294K 0.3% 71

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FNY Investment Advisers's CDLX Position: Q4 2025 in Review

FNY Investment Advisers sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 1,367 shares — an estimated $33K sold.

FNY Investment Advisers first reported a position in CDLX in Q1 2024 and held it in 3 quarters. The position peaked at $61K in Q2 2024. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • FNY Investment Advisers reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 1,367 Cardlytics shares in Q4 2025, an estimated $33K.
  • FNY Investment Advisers first reported a position in Cardlytics in Q1 2024 and held it in 3 quarters.
  • FNY Investment Advisers's Cardlytics position peaked at $61K in Q2 2024.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.